MedTrace Logo

HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies

NCT03213314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2019-10-04

No results posted yet for this study

Summary

This observational clinical cohort study aims to evaluate the clinical utility of LiverMultiScan in quantifying liver health prior to liver resection or TACE. The results will enable further developments in scanning protocols and software, and clearly define the relevance of applying this technology as part of the pre-operative assessment of the patient being considered for liver resection or TACE.

Conditions

  • Liver Cancer
  • Surgery
  • Liver Regeneration
  • Colorectal Cancer Metastatic

Interventions

DIAGNOSTIC_TEST

Multiparameter magnetic resonance imaging

LiverMultiScan before and after surgery to assess liver health prior to liver resection and in the regenerative phase.

Sponsors & Collaborators

  • Hampshire Hospitals NHS Foundation Trust

    collaborator OTHER

  • Perspectum

    collaborator INDUSTRY

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Damian J Mole, MBChB PhD · University of Edinburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-07
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03213314 on ClinicalTrials.gov